✦ LIBER ✦

Improvement by the insulin-sensitizing agent, troglitazone, of abnormal fibrinolysis in type 2 diabetes mellitus

✍ Scribed by Ken Kato; Daishiro Yamada; Sanae Midorikawa; Wakano Sato; Tsuyoshi Watanabe

Book ID: 117179605
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 386 KB
Volume: 49
Category: Article
ISSN: 1532-8600
DOI: 10.1016/s0026-0495(00)80045-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Will acarbose improve the metabolic abno

Will acarbose improve the metabolic abnormalities of insulin-resistant type 2 diabetes mellitus?

✍ R Scott; C.J Lintott; P Zimmet; L Campbell; K Bowen; T Welborn 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 265 KB

The effects of troglitazone, an insulin-

The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: A placebo-controlled randomized clinical trial

✍ A.Enrique Caballero; Rola Saouaf; Su Chi Lim; Osama Hamdy; Karim Abou-Elenin; Co 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 100 KB

Improvement of lipid profile in Type 2 (

Improvement of lipid profile in Type 2 (non-insulin-dependent) diabetes mellitus by insulin-like growth factor I

✍ P. D. Zenobi; P. Holzmann; Y. Glatz; W. F. Riesen; E. R. Froesch 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 594 KB

Type 2 (non-insulin-dependent) diabetes mellitus is associated with increased glucose, insulin, total and VLDL-triglyceride, and often total and LDL-cholesterol levels which promote vascular disease. Recombinant human insulin-like growth factor-I which mimics many effects of insulin, decreased insul

Insulin lispro in the treatment of patie

Insulin lispro in the treatment of patients with type 2 diabetes mellitus after oral agent failure

✍ Edward J. Bastyr III; Martin E. Johnson; Michael E. Trautmann; James H. Anderson 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 865 KB

(−)-BM 13.0913: A new oral antidiabetic

(−)-BM 13.0913: A new oral antidiabetic agent that improves insulin sensitivity in animal models of type II (non—insulin-dependent) diabetes mellitus

✍ P. Freund; H.P. Wolff; H.F. Kühnle 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 605 KB

Rationale for the Use of Insulin Sensiti

Rationale for the Use of Insulin Sensitizers to Prevent Cardiovascular Events in Type 2 Diabetes Mellitus

✍ Vivian A. Fonseca 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 748 KB